Juvenile Huntington's Disease FDA Patient Listening Session Summarykatie8288Apr 4, 20230 min readJoHD FDA PLS Review.pdfDownload PDF • 509KB
Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease
Comments